# Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk

> **NCT06845423** · PHASE4 · RECRUITING · sponsor: **University Hospital, Brest** · enrollment: 2400 (estimated)

## Conditions studied

- Venous Thromboembolism (VTE)
- Post Partum Women

## Interventions

- **DRUG:** Low molecular weight heparin

## Key facts

- **NCT ID:** NCT06845423
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-16
- **Primary completion:** 2028-05-16
- **Final completion:** 2028-08-16
- **Target enrollment:** 2400 (ESTIMATED)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06845423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06845423, "Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06845423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*